As many as 24 human guinea pigs will be paid £3,500 to take participate in the trial which will see them infected with the deadly coronavirus and banned from physical contact with the outside world for two weeks.
As reported in The Times, Those taking who will take part in this experiment will be held in a special quarantine lab in east London owned by medical testing company Hvivo.
Scientists are working round the clock to develop a vaccine by next winter to protect the people who have underlying health conditions and the elderly.
As of this writing, more than 2 million dollars have been invested worldwide and a total of 20 firms and public sector organisations are taking part on the global effort to develop a cure.
Earlier this week, Boris Johnson reported to have pledged £46 million (approximately $60 million) for research into a coronavirus vaccine and rapid diagnostic tests.
The Prime Minister announced the funding during a tour of a Bedfordshire laboratory, where British scientists are working on a quick and cheap way to diagnose coronavirus.
According to Mr. Johnson, there is currently no vaccine available to protect the people against the deadly Covid-19, but he is hoping that one will be ready in about a year.
Chris Whitty, England’s Chief Medical Officer Professor has previously said the United Kingdom will not have a vaccine available for the first wave of a pandemic, but that it is still important to develop one for any future pandemic waves.
Global human trials of eight possible vaccines could start later this year. But firms would then face the task of mass-producing and distributing them.
Public Health England (PHE) has developed methods of testing for coronavirus, but more rapid diagnostic tests are needed as these currently rely on samples being sent to a lab.
According to Downing Street, the United Kingdom’s investment into the coronavirus vaccine research is now worth £65 million ($85 million), with £91 million ($119 million) in total for international work to prevent the spread of the virus.